Survivorship, Late Effects and Cancer of the Cervix

Clinical Oncology

Volumn 20, Issue 6, 2008, Pages 479-487

  Maher, E J ^a   Denton, A ^a  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

Cervix cancer; follow up; late effects; pelvic radiotherapy; survivorship

Indexed keywords

ANTINEOPLASTIC AGENT; BOTULINUM TOXIN A; CISPLATIN; FLAVOXATE; MUSCARINIC RECEPTOR BLOCKING AGENT; OXYBUTYNIN; PHENYLEPHRINE; STEROID; TETRACHLORODECAOXIDE; TOLTERODINE;

ARTICLE; BALANCE DISORDER; BLADDER DISEASE; CANCER INCIDENCE; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CHRONIC DISEASE; CLINICAL TRIAL; DIARRHEA; DISABILITY; ENDOMETRIUM CANCER; ENTERITIS; FATIGUE; FECES INCONTINENCE; FEMALE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL TOXICITY; HUMAN; KIDNEY INJURY; LONG TERM CARE; LYMPHEDEMA; MENOPAUSE; MENTAL DISEASE; NEUROPATHY; OVARY CANCER; OVERACTIVE BLADDER; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROCTITIS; QUALITY OF LIFE; RADIATION INJURY; SEXUAL FUNCTION; UNSPECIFIED SIDE EFFECT; URINARY TRACT DISEASE; UTERINE CERVIX CANCER;

ADAPTATION, PSYCHOLOGICAL; FEMALE; HUMANS; PALLIATIVE CARE; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SURVIVAL; TIME FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 46249096337     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2008.04.009     Document Type: Article

References (94)

1. Hewitt M., Rowland J.H., and Yancik R. Cancer survivors in the United States: age, health and disability. J Gerontol 58 (2003) 82-91
2. Basen E.K., and Bodurka D.C. Medical and psychosocial issues in gynaecological cancer survivors. In: Ganz P. (Ed). Cancer survivorship today and tomorrow (2007), Springer, Berlin 114-121
3. Yabroff K.R., Davis W.W., Lamont E.B., et al. Patient time costs associated with cancer care. J Natl Cancer Inst 99 (2007) 14-23
4. Macmillan Cancer Support. Cancer costs 2006. Available from:. www.macmillan.org.uk
5. Macmillan Cancer Support. Access denied. Available from:. www.macmillan.org.uk
6. Mullan R. Seasons of survival: reflections of a physician with cancer. N Engl J Med 313 (1985) 270-273
7. Richardson A., Crowe M., Armes J., et al. Establishing a cancer nursing research workgroup: a study of the supportive care needs of people following cancer treatment. Research results (2007), King's College, London
8. Hodgkinson K., Butow P., Fuchs A., et al. Long-term survival from gynaecological cancer: psychosocial outcomes, supportive care needs and positive outcomes. Gynecol Oncol 104 (2007) 381-389
9. Hurt G.J., McQuellon R.P., and Barrett R.J. After treatment ends. Cancer Pract 2 (1994) 417-420
10. Hwang S.H., Chang V.T., Cogswell J., et al. Study of unmet supportive care needs in symptomatic veterans with advanced cancer: incidence, independent predictors and unmet needs outcome model. J Pain Symptom Manage 28 (2004) 421-432
11. Boice J.D.J., Engholm G., Kleinerman R.A., et al. Radiation dose and second cancer risk in patients treated for cancer of the cervix. Radiat Res 116 (1988) 3-55
12. Kleinerman R., Boice J.J., Storm H., et al. Second primary cancer after treatment for cervical cancer. An international cancer registries study. Cancer 76 (1995) 442-452
13. Ganatra A.M., and Loughlin K.R. The management of malignant ureteral obstruction treated with ureteral stents. J Urol 174 6 (2005) 2125-2128
14. Feuer G.A., Fruchter R., Seruri E., Maiman M., Remy J.C., and Boyce J.G. Selection for percutaneous nephrostomy in gynecologic cancer patients. Gynecol Oncol 42 1 (1991) 60-63
15. Fried T.R., Bradley E.H., O`Leary J.R., et al. Unmet desire for caregiver - patient communication and increased caregiver burden. J Am Geatr Soc 53 (2005) 59-65
16. Goldstein N.E., Concato J., Fried T.R., et al. Factors associated with caregiver burden among caregivers of terminally ill patients with cancer. J Palliat Care 20 (2004) 38-43
17. Ries L.A.G., Eisner M.P., Kosary C.L., et al. Seer statistics review 1975-2000 (2003), Bethesda National Cancer Institute, Bethesda
18. Cancer Research UK. Available from:. www.info.cancerresearchuk.org/cancerstats/types/cervix/incidence [accessed 06.02.07]
19. Mead G. The effects of cancer treatment on reproductive functions. Clin Med 6 (2007) 544-545
20. Coulter A., and Ellins E. Patient-focussed interventions (2006), Picker Institute Europe, Oxford
21. Basen-Engquist K., Electra D., Paskett E., et al. Cervical cancer and behavioural factors related to screening diagnosis and survivors' quality of life. Cancer 98 Suppl (2003) 2009-2014
22. Kjaer S.K., Engholm G., Dant C., and Bock J.E. Case-control study of risk factors for cervical squamous cell neoplasia in Denmark. IV: Role of smoking habits. Eur J Cancer Prev 5 (1996) 359-365
23. Ilkenstein W. Smoking and cervical cancer - current status: a review. J Epidemiol 131 (1990) 945-957
24. Management of cervical cancer. Available from:. www.sign.ac.uk
25. Rehse B., and Pukrop R. Effects of psychosocial interventions on quality of life in adult cancer patients: meta analysis of 37 published controlled outcome studies. Patient Educ Couns 50 2 (2003) 179-186
26. National Breast Cancer Centre and National Cancer Control Initiative. Clinical practice guidelines for the psychosocial care of adults with cancer (2003), National Breast Cancer Centre 2003, Camperdown. http://www.nhmrc.gov.au/publications/synposes/files/cp90.pdf Available from:
27. Petersen R.W., and Quinliven J.A. Preventing anxiety and depression in gynaecological cancer: a randomized controlled trial. Br J Obstet Gynaecol 109 (2002) 386-394
28. University of York NHS Centre for Reviews & Dissemination. Management of gynaecological cancers. Available from:. http://www.york.ac.uk/inst/crd/ehc53.pdf
29. Plache E. Hormonal replacement therapy in patients after cervical cancer treatment. Gynecol Oncol 26 2 (1987) 169-177
30. Lacey Jr. J.V., Brinton L.A., Barnes W.A., et al. Use of hormone replacement therapy and adenocarcinomas and squamous cell carcinomas of the uterine cervix. Gynecol Oncol 77 1 (2000) 149-154
31. Ryan M., Stainton M.C., Slaytor E.K., et al. Aetiology and prevalence of lower limb lymphoedema following treatment for gynaecological cancer. Aust N Z J Obstet Gynecol 43 (2003) 148-151
32. Lymphoedema Framework. Best practice for the management of lymphoedema. International consensus (2006), MEP, London
33. Badger C., Preston N., Sers K., and Mortimer P. Physical therapies for reducing and controlling lymphoedema of the limbs. Cochrane Database Syst Rev Issue 4 (2004)
34. Andreyev J. Gastrointestinal symptoms after pelvic radiotherapy: a new understanding symptomatic patients. Lancet Oncol 8 (2007) 1007-1017
35. Denton A.S., Bentzen S.M., and Maher E.J. How useful are observational reports in the evaluation of interventions for radiation morbidity? An analysis of formalin therapy for late radiation proctitis. Radiother Oncol 64 3 (2002) 291-295
36. Denton A.S., Bond S.J., Matthews S., Bentzen S.M., Maher E.J., and the UK Link Gynae-Oncology Group. National audit of the management and outcome of cancer of the cervix treated with radiotherapy in 1993. Clin Oncol 12 6 (2000) 347-353
37. Denton A.S., Bond S.J., Matthews S., Bentzen S.M., Maher E.J., and the UK Link Gynae-Oncology Group. Treatment-related morbidity and hospital league tables: experience from a national audit of radiotherapy-induced morbidity in cervical carcinoma. Clin Oncol 14 (2002) 40-44
38. Maher E.J., and Makin W. Life after cancer treatment. A spectrum of chronic survivorship conditions. Clin Oncol 10 (2007) 743-745
39. Green J., Kirwan J., Tierney J., et al. Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix. Cochrane Database Syst Rev Issue 3 (2005)
40. Peters W.A., Liu P.Y., Barrett R.J., et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early stage cancer of the cervix. J Clin Oncol 18 (2000) 1606-1613
41. DiSaia PJ, Creasman WT. Clinical Gynecologic Oncology. Mosby: Elsevier. ISBN:978-0-323-03978-9.
42. King M., McConkey C., Latief T.N., et al. Improved survival after concurrent weekly cisplatin and radiotherapy for cervical carcinoma with assessment for acute and late side effects. Clin Oncol 18 (2006) 38-45
43. Vicary P., Johnson M., Maher E.J., and on behalf of patient representatives of the Macmillan Late Effects Project Group. Personal View. To my oncologist - an open letter from a patient at the end of follow-up. Clin Oncol 19 (2007) 746-747
44. Klee T., and Machin D. The patients' perspective on physical symptoms after radiotherapy for cervix cancer. Gynaecol Oncol 76 (2000) 14-23
45. Bye A., Trope C., Ioge J.H., Hjermstad M., and Kaasa S. Health related quality of life occurence of intestinal side effects after pelvic radiotherapy evaluation of long term effects of diagnosis and treatment. Acta Oncol 39 (2000) 173-180
46. Given CW, Given B, Azzouz F, et al. Predictors of pain and fatigue in the year following diagnosis among elderly cancer patients. J Pain Symptom Manage 21:456-60.
47. Denton A.S., and Maher E.J. Interventions for the physical aspects of sexual dysfunction in women following pelvic radiotherapy. Cochrane Database Syst Rev Issue 1 (2003)
48. National Forum of Gynaecological Oncology Nurses. Best practice guidelines on the use of vaginal dilators in women receiving pelvic radiotherapy (2005), Owen Mumford, Woodstock. Available from: www.ukons.org/storage/dilators_guidelines.pdf
49. Robinson J.W., Faris P.D., and Scott C.B. Psychoeducational group increases vaginal dilation for younger women and reduces sexual fears for women of all ages with gynecological carcinoma treated with radiotherapy. Int J Radiat Oncol Biol Phys 43 (1999) 497-506
50. Denton A.S., Clarke N.W., and Maher E.J. Non-surgical interventions for the management of late radiation cystitis. Cochrane Database Syst Rev 3 (2002) CD001773
51. Parkin D.E., Davis J.A., and Symonds R.P. Long-term bladder symptomatology following radiotherapy for cervical carcinoma. Radiother Oncol 9 3 (1987) 195-199
52. Parkin D.E., Davis J.A., and Symonds R.P. Urodynamic findings following radiotherapy for cervical carcinoma. Br J Urol 61 3 (1988) 213-217
53. Veerasam V., Khorprasert C., Lorvidhaya V., et al. Reduced recurrence of late hemorrhagic radiation cystitis by WF10 therapy in cervical cancer patients: a multicenter, randomized, two-arm, open-label trial. Radiother Oncol 73 2 (2004) 179-185
54. Ehren I., Voiz D., Farrelly E., et al. Efficacy and impact of botulinum toxin A on quality of life in patients with neurogenic detrusor overactivity; a randomised, placebo-controlled, double-blind study. Scand J Urol Nephrol 41 4 (2007) 335-340
55. Gami B., Harrington K., Blake P., et al. How patients manage gastrointestinal symptoms after pelvic radiotherapy. Aliment Pharmacol Ther 18 (2003) 987-994
56. Widmark A., Fransson P., and Tavelin B. Self-assessment questionnaire for evaluating urinary and intestinal late side effects after pelvic radiotherapy in patients with prostate cancer compared with an age-matched control population. Cancer 74 (1994) 2520-2532
57. Crook J., Esche B., and Futter N. Effect of pelvic radiotherapy for prostate cancer on bowel, bladder and sexual function: the patient's perspective. Urology 47 (1996) 387-394
58. al-Abany M., Helgason A., Cronqvist A., et al. Long-term symptoms after external beam radiation therapy for prostate cancer with three or four fields. Acta Oncol 4 (2002) 532-542
59. Henningsohn I., Wijkstrom H., Dickman P., et al. Distressful symptoms after radical radiotherapy for urinary bladder cancer. Radiother Oncol 62 (2002) 215-225
60. Fokdal J., Hoyer M., Meldgaard P., and von der Masse H. Long-term bladder, colorectal and sexual functions after radical radiotherapy for urinary bladder cancer. Radiother Oncol 72 (2004) 139-145
61. Bergmark K., Avall-Lundqvist F., Dickman P., et al. Patient-rating of distressful symptoms after treatment for early cervical cancer. Acta Obstet Gynecol Scand 81 (2002) 443-450
62. Putta S., and Andreyev H.J.N. Faecal incontinence - a late side effect of pelvic radiotherapy. Clin Oncol 7 (2005) 469-477
63. Davidson S.E., et al. Assessment of morbidity in carcinoma of the cervix: a comparison of the LENT SOMA scales and the Franco-Italian glossary. Radiother Oncol 69 (2003) 195-200
64. Ul Y.A., Prasannan S., Jabar F.M., Shaker A.R., and Moissinac K. Pharmacotherapy for chronic hemorrhagic radiation proctitis. World J Surg 26 1 (2002) 499-502
65. Denton A.S., Andreyev J., Forbes A.L., and Maher E.J. Systematic review for non-surgical interventions for the management of late radiation proctitis. Br J Cancer 87 2 (2002) 134-143
66. Manojlovic N., and Babic D. Radiation-induced rectal ulcer - prognostic factors and medical treatment. Hepatogastroenterology 51 56 (2004) 447-450
67. Yeoh E., Horowitz M., Russo A., et al. Effect of pelvic irradiation on gastrointestinal function. Am J Med 94 (1993) 397-406
68. Badvie S., and Andreyev H.J.N. Topical phenylephrine in the treatment of radiation-induced faecal incontinence. Clin Oncol 17 (2005) 122-126
69. In: Booth S., Bruera E., and Tate T. (Eds). Palliative care consultations in gynaecology (2004), Oxford University Press, Oxford
70. Late effects of pelvic radiotherapy (men & women). Available from:. www.cancerbackup.org.uk
71. Scott J.T., Harmsen M., Prictor M.J., Entwistle V.A., Sowden A.J., and Watt I. Recordings of summaries of consultations for people with cancer. Cochrane Database Syst Rev Issue 2 (2003)
72. Harris K. The informal needs of patients with cancer and their families. Cancer 6 1 (1998) 39-46
73. Ataman O.U., Barrett A., Davidson S., et al. Audit of effectiveness of routine follow-up clinics after radiotherapy for cancer: a report of the REACT working group of ESTRO. Radiother Oncol 73 2 (2004) 237-249
74. Bodurka-Bevers D., Morris M., Eifel P.J., et al. Post-therapy surveillance of women with cervical cancer: an outcomes analysis. Gynecol Oncol 78 2 (2000) 187-193
75. Hong J.H., Isar C.S., Lar C.H., et al. Recurrent squamous cell carcinoma of cervix after definitive radiotherapy. Int J Radiat Oncol Biol Phys 60 1 (2004) 249-257
76. Lim K.C.K., Howells R.E.J., and Evans A.S. The role of clinical follow up in early stage cervical cancer in South Wales. Br J Obstet Gynaecol 111 12 (2004) 1444-1448
77. Park D.H., Kim K.H., Park S.Y., Lee B.H., Choi C.W., and Chin S.Y. Diagnosis of recurrent uterine cervical cancer: computed tomography versus positron emission tomography. Korean J Radiol 1 1 (2000) 51-55
78. Husain A., Akhurst T., Larson S., Alektiar K., Barakat R.R., and Chi D.S. A prospective study of the accuracy of 18 fluorodeoxyglucose positron emission tomography (18FDG PET) in identifying sites of metastasis prior to pelvic exenteration. Gynecol Oncol 106 1 (2007) 177-180
79. Maher E.J., Watson I., Makin W., et al. Chronic bowel dysfunction after radiotherapy EAPC. Budapest: (2007)
80. Wilson J. Living with bowel problems following radiotherapy: a coping study commissioned by NACC - the National Association for Colitis and Crohn's Disease, March 2006.
81. Bentzen S.M., Dorr W., Anscher M.S., et al. Normal tissue effects: reporting and analysis. Semin Radiat Oncol 13 (2003) 189-202
82. Trotti A., Colevas A.D., Setser A., et al. Patient-reported outcomes and the evolution of adverse event reporting in oncology. J Clin Oncol 25 32 (2007) 5121-5127
83. Osoba D. Translating the science of patient reported outcomes assessment into clinical practice. Int Cancer Inst Monograph 35 (2007) 5-11
84. LENT SOMA tables. Radiother Oncol 36 (1995) 17-60
85. LENT SOMA scales for all anatomic sites. Int J Radiat Oncol Biol Phys 31 (1995) 1049-1091
86. Routledge J.A., Burns M.P., Swindell R., et al. Evaluation of the LENT SOMA scales for the prospective assessment of treatment morbidity in cervical carcinoma. Int J Radiat Oncol Biol Phys 56 (2003) 502-510
87. Chassange D., et al. A glossary for reporting complications of treatment in gynaecological tumours. Radiother Oncol 26 (1993) 196-202
88. Osoba D. Translating the science of patient-reported outcomes assessment into clinical practice. J Natl Cancer Inst Monogr 37 (2007) 5-11 (Review)
89. Glare P., Virik K., Jones M., et al. A systematic review of physicians' survival predictions in terminally ill cancer patients. Br Med J 327 (2003) 195-198
90. Grunfeld E.A., Maher E.J., Browne S., et al. Advanced breast cancer patients's percetions Advanced breast cancer patients' perceptions of decision making for palliative chemotherapy. J Clin Oncol 24 7 (2006) 1090-1098
91. Gatellari M., Butow P.N., Tattersall M.H.N., et al. Misunderstandings in cancer patients. Ann Oncol 10 (1999) 39-46
92. Lamont E.B., Christakis N.A., et al. Physician factors in the timing of cancer patient referral to hospice palliative care. Cancer 94 (2002) 2733-2737
93. Weeks J.C., Cook E.F., O'Day S.J., et al. Relationship between cancer patients' predictions of prognosis and their treatment preferences. J Am Med Assoc 279 (1998) 1709-1714
94. Harding R., and Higginson I. Working with ambivalence: informal caregivers of patients at the end of life. Support Care Cancer 9 (2001) 642-645